Insights

Home Insights

Evidence Is the Product – Rethinking U.S FDA Device Testing

Understanding the Logic Behind the Evidence Navigating FDA expectations doesn’t have to be a guessing game. Does the device perform as described? Have relevant risks been identified and mitigated? Is patient interaction acceptably safe? Does evidence support the intended use and labeling? Where necessary, are clinical data sufficient to address residual questions? Across 510(k), De Novo, [...]